NasdaqCM - Nasdaq Real Time Price USD

HOOKIPA Pharma Inc. (HOOK)

0.8933 +0.0872 (+10.82%)
At close: 4:00 PM EDT
0.9000 +0.01 (+0.75%)
After hours: 7:35 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
20,129.0000
20,129.0000
14,249.0000
18,448.0000
19,584.0000
Operating Expense
93,864.0000
93,864.0000
79,488.0000
90,398.0000
66,352.0000
Operating Income
-73,735.0000
-73,735.0000
-65,239.0000
-71,950.0000
-46,768.0000
Net Non Operating Interest Income Expense
4,976.0000
4,976.0000
946.0000
-871.0000
-386.0000
Other Income Expense
-12,453.0000
-12,453.0000
-392.0000
-2,843.0000
3,072.0000
Pretax Income
-81,212.0000
-81,212.0000
-64,685.0000
-75,664.0000
-44,082.0000
Tax Provision
368.0000
368.0000
230.0000
1.0000
--
Net Income Common Stockholders
-81,580.0000
-81,580.0000
-64,915.0000
-75,665.0000
-44,082.0000
Diluted NI Available to Com Stockholders
-81,580.0000
-81,580.0000
-64,915.0000
-75,665.0000
-44,082.0000
Basic EPS
-0.86
--
-0.99
-2.30
-1.69
Diluted EPS
-0.86
--
-0.99
-2.30
-1.69
Basic Average Shares
94,526.5610
--
65,570.7070
32,833.5900
26,084.0240
Diluted Average Shares
94,526.5610
--
65,570.7070
32,833.5900
26,084.0240
Total Operating Income as Reported
-97,694.0000
-97,694.0000
-73,155.0000
-81,674.0000
-53,285.0000
Total Expenses
93,864.0000
93,864.0000
79,488.0000
90,398.0000
66,352.0000
Net Income from Continuing & Discontinued Operation
-81,580.0000
-81,580.0000
-64,915.0000
-75,665.0000
-44,082.0000
Normalized Income
-68,877.8300
-68,877.8300
-64,915.0000
-75,665.0000
-44,082.0000
Interest Income
5,293.0000
5,293.0000
1,633.0000
27.0000
400.0000
Interest Expense
317.0000
317.0000
687.0000
898.0000
786.0000
Net Interest Income
4,976.0000
4,976.0000
946.0000
-871.0000
-386.0000
EBIT
-80,895.0000
-80,895.0000
-63,998.0000
-74,766.0000
-43,296.0000
EBITDA
-77,343.0000
-77,343.0000
-60,396.0000
-70,126.0000
-39,146.0000
Reconciled Depreciation
3,552.0000
3,552.0000
3,602.0000
4,640.0000
4,150.0000
Net Income from Continuing Operation Net Minority Interest
-81,580.0000
-81,580.0000
-64,915.0000
-75,665.0000
-44,082.0000
Total Unusual Items Excluding Goodwill
-12,766.0000
-12,766.0000
--
--
--
Total Unusual Items
-12,766.0000
-12,766.0000
--
--
--
Normalized EBITDA
-64,577.0000
-64,577.0000
-60,396.0000
-70,126.0000
-39,146.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
--
--
Tax Effect of Unusual Items
-63.8300
-63.8300
--
--
--
12/31/2020 - 4/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PCSA Processa Pharmaceuticals, Inc.
2.1500
-11.52%
 
ABVC ABVC BioPharma, Inc.
1.4200
-10.69%
 
NKGN NKGen Biotech, Inc.
1.6100
-18.69%
 
CYCC Cyclacel Pharmaceuticals, Inc.
1.5100
-5.63%
 
ASLN ASLAN Pharmaceuticals Limited
0.4153
-7.30%
 
PALI Palisade Bio, Inc.
6.05
-2.89%
 
PHIO Phio Pharmaceuticals Corp.
0.6820
+1.34%
 
SILO Silo Pharma, Inc.
1.8500
-2.63%
 
MLEC Moolec Science SA
1.4500
+2.11%
 
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%